Formulating Cannabinoid Particles for Therapeutics

Recent literature increasingly supports the therapeutic use of cannabinoids in the development of novel medicines. Nanoparticles play a crucial role in increasing the solubility, stability, benefits and safety of cannabinoids as therapeutic agents. In this webinar, we review the challenges of cannabinoid-based drug development, and present the opportunities of nanotechnology in formulating cannabinoid nanoparticles.

During this webinar we will discuss:

• Clinical Snapshot: History and challenges of cannabinoid-based drug development
• Technology Overview: Opportunities in nanotechnology and the microfluidic approach
• Characterization Methods: ELISA for dissolution studies
• Sample Preparation Challenges: Polymer nanoparticles, liposomes, emulsions on the HPLC
• Research Findings: The impact of lipid composition on liposome stability and cannabinoid drug encapsulation efficiency

Presenter: Dr Natalia Sannikova (Research & Development Manager, Ascension Sciences)

Presenter: Tomas Skrinskas (Founder & CEO, Ascension Sciences)